Practice in relation to administration of methotrexate varies considerably despite its prominent place in the treatment arsenal for various rheumatic diseases. A multinational initiative has developed ...
The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for ADX-2191 (methotrexate injection) for the treatment of primary vitreoretinal lymphoma, a rare ...
For decades, methotrexate has formed the foundation of therapy in RA, either alone or in combination with other drugs; however, its mechanisms of action remain poorly understood, and many patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results